TechKim

China Biotech Week in Review: Earnings, Deals and Drug Development

CPHI selling 5 million shares at a below-market price of $2. then giving investors 1.25 million three-year warrants to buy additional shares at $2.80 is a major concern to investors. Reporting uncollected revenue increase is deceitfull, by then following it up with a private placement.

I wonder how the recent donations will be reported?

China Pharma Delivers on Improved Financials Promise

additional comment. I would also tend to whole heartly believe that the upcoming conference will severly address the accounts receivable backlog and how it is being resolved. I would also tend to believe that once the company clearifies some of these issues that the share price will grow. I would suggest adding shares before the conference.

Conference Call

China Pharma will host a conference call on Tuesday, May 6 at 10:00 am EDT to discuss first quarter 2008 results. To participate in the conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: [phone] International callers should dial [phone]. The conference pass code is 32765641.

If you are unable to participate in the call at this time, a replay will be available on Tuesday, May 6, at 12:00 pm EDT, through Tuesday, May 13. To access the replay, dial [phone]. International callers should dial [phone]. The conference pass code is 89227480.

This conference call will be broadcast live over the Internet and can be accessed by copying and pasting this link into your web browser: phx.corporate-ir.net/p...- eventDetails&c=145... A replay of the call will also be available on China Pharma's website www.chinapharmaholding... for 90 days.

China Pharma Delivers on Improved Financials Promise

In addition to my comment.

The negativity has not been fully addressed in regards to the accounts receivables.

I am at least addressing the reason. I am also addressing what I believe is behind the backlog. I also believe I have relieved some of the negativity.


If you were a new investor! Would you also not want to know why this company has $24m in accounts receivables and not in the bank?

A new investor could look at the $24m as earnings of $0.60 per share or as $0.60 per share of bad debt.

I for one WANT to believe that the $24.8m in accounts receivable backlog is as good as money in the bank.

China Pharma Delivers on Improved Financials Promise

All this excitement about accounts receivables possibly turning into bad debt. Basically from what I can gather together. It is the Chinese Government Hospitals that are slow in paying. All the while it is the Chinese Government that is growing the medical service distribution network to a 100% level. American hospitals are basically famous for allowing their vendors to wait nearly six months to be paid. Is it very much different in China? I doubt that CPHI is the only medical supplier that has an account receivable backlog.

China Pharma Delivers on Improved Financials Promise

All this excitement about accounts receivables possibly turning into bad debt. Basically from what I can gather together. It is the Chinese Government Hospitals that are slow in paying. All the while it is the Chinese Government that is growing the medical service distribution network to a 100% level. American hospitals are basically famous for allowing their vendors to wait nearly six months to be paid. Is it very much different in China? I doubt that CPHI is the only medical supplier that has an account receivable backlog.